A clinical trial to evaluate iron preparation effect for the pulmonary hypertension secondary in chronic respiratory disease patients - Secondary PH-Fe study

Osaka City General Hospital Department of Respiratory Medicine0 个研究点目标入组 41 人开始时间: 2012年4月26日最近更新: 2023年10月17日

适应症

试验速览

暂无简介。

•1.Patient's fever is 38 degrees or more within one week before screening test 2.Patients complicated with active tuberculosis and atypical mycobacterial disease 3.Patients with active respiratory tract infection in chest Xp or clinical examination 4.Patients with active heart failure with the hemostatic findings in chest Xp **But, we make it possible to conduct a screening test after hemostatic findings disappeared in case that recognized hemostatic findings in chest X-rays. 5.Patients with pneumothorax in chest Xp 6.Patients with pleural effusion that drainage needs 7.Patients with history of hypersensitivity with iron preparation formulation 8.Patients who are complicated with apparent hepatic cirrhosis or active hepatitis 9.Patients with history of paroxysmal nocturnal hemoglobinemia 10.Patients with apparent renal failure 11.The patients in acknowledgment of exacerbation with existing illness within one month from screening test 12.A pregnant woman or the patients with the possibility to become pregnant and nursing patients 13.In addition, the patients whom doctor attending judged to be inadequate as a study candidate

发起方

Osaka City General Hospital Department of Respiratory Medicine